<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE nitf SYSTEM "http://www.nitf.org/IPTC/NITF/3.3/specification/dtd/nitf-3-3.dtd">
<nitf change.date="June 10, 2005" change.time="19:30" version="-//IPTC//DTD NITF 3.3//EN">
  <head>
    <title>Pap Tests and Annual Exams</title>
    <meta content="23lett-1" name="slug"/>
    <meta content="23" name="publication_day_of_month"/>
    <meta content="1" name="publication_month"/>
    <meta content="2007" name="publication_year"/>
    <meta content="Tuesday" name="publication_day_of_week"/>
    <meta content="Science Desk" name="dsk"/>
    <meta content="4" name="print_page_number"/>
    <meta content="F" name="print_section"/>
    <meta content="1" name="print_column"/>
    <meta content="Science; Opinion" name="online_sections"/>
    <docdata>
      <doc-id id-string="1820931"/>
      <doc.copyright holder="The New York Times" year="2007"/>
      <identified-content>
        <classifier class="indexing_service" type="descriptor">Cancer</classifier>
        <classifier class="indexing_service" type="descriptor">Women</classifier>
        <classifier class="indexing_service" type="descriptor">Cervix</classifier>
        <classifier class="indexing_service" type="descriptor">Pap Test</classifier>
        <classifier class="indexing_service" type="descriptor">Research</classifier>
        <classifier class="indexing_service" type="descriptor">Tests and Testing</classifier>
        <classifier class="indexing_service" type="descriptor">Human Papilloma Virus (Hpv)</classifier>
        <classifier class="indexing_service" type="descriptor">Sexually Transmitted Diseases</classifier>
        <person class="indexing_service">Brightman, Rebecca C (Dr)</person>
        <classifier class="online_producer" type="types_of_material">Letter</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/Science</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Opinion</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Opinion/Opinion</classifier>
        <classifier class="online_producer" type="general_descriptor">Anatomy and Physiology</classifier>
        <classifier class="online_producer" type="general_descriptor">Cancer</classifier>
        <classifier class="online_producer" type="general_descriptor">Research</classifier>
        <classifier class="online_producer" type="general_descriptor">Venereal Diseases</classifier>
        <classifier class="online_producer" type="general_descriptor">Viruses</classifier>
        <classifier class="online_producer" type="general_descriptor">Women</classifier>
        <classifier class="online_producer" type="general_descriptor">Tests and Testing</classifier>
        <classifier class="online_producer" type="general_descriptor">Diseases and Conditions</classifier>
        <classifier class="online_producer" type="general_descriptor">Medicine and Health</classifier>
      </identified-content>
    </docdata>
    <pubdata date.publication="20070123T000000" ex-ref="http://query.nytimes.com/gst/fullpage.html?res=9D00EED81F30F930A15752C0A9619C8B63" item-length="112" name="The New York Times" unit-of-measure="word"/>
  </head>
  <body>
    <body.head>
      <hedline>
        <hl1>Pap Tests and Annual Exams</hl1>
      </hedline>
      <abstract>
        <p>Dr Rebecca C Brightman letter on January 16 article about cervical cancer reminds women of importance of regular gynecologic examinations</p>
      </abstract>
    </body.head>
    <body.content>
      <block class="lead_paragraph">
        <p>To the Editor:</p>
        <p>Re: ''Pap Test, a Mainstay Against Cervical Cancer, May Be Fading'' (Jan. 16): The development of HPV testing has undoubtedly played a huge role in the detection and treatment of cervical cancer. The advent of Gardasil will decrease the incidence of this cancer. Now more studies confirm the fact that women who have a negative test may need Pap smears less frequently.</p>
      </block>
      <block class="full_text">
        <p>To the Editor:</p>
        <p>Re: ''Pap Test, a Mainstay Against Cervical Cancer, May Be Fading'' (Jan. 16): The development of HPV testing has undoubtedly played a huge role in the detection and treatment of cervical cancer. The advent of Gardasil will decrease the incidence of this cancer. Now more studies confirm the fact that women who have a negative test may need Pap smears less frequently.</p>
        <p>It is very important for women to realize that the Pap smear is only a portion of the annual gynecologic examination. An annual (and for some patients semiannual) evaluation of a woman's thyroid, breasts and pelvic organs remains essential.</p>
        <p>Rebecca C. Brightman, M.D.  New York</p>
      </block>
    </body.content>
  </body>
</nitf>
